M&A & Strategic Transactions
Buy-side, sell-side, licensing, and partnership execution, integrating commercial, market, and regulatory considerations.
What We Offer
Transaction Strategy & Deal Structuring
Clarify objectives, strategic fit, and value creation logic for both first-time and experienced dealmakers.
Target Screening & Opportunity Sourcing
Identify and prioritise acquisition, licensing, or partnership opportunities aligned with strategic and regional priorities.
Commercial & Regulatory Diligence
Assess market attractiveness, competitive dynamics, and regulatory implications to support confident decision-making.
Deal Execution & Stakeholder Coordination
Provide support across negotiations and execution, aligning internal teams and external transaction stakeholders across regions.
Why Clients Engaging Us
'We are considering an acquisition in China/Europe and want experienced guidance to avoid mistakes that are easy to make but expensive to fix.'
'We have transaction experience, but cross-border complexity, culture, and regulatory risk increase execution uncertainty.'
'Interpreting signals, expectations, and behaviour across different cultures and decision styles is not straightforward.'
'We need hands-on support from someone who has managed similar cross-border transactions before, not just theoretical advice.'
Why You Can Trust Us
Our team includes experienced dealmakers with extensive hands-on transaction experience in life sciences, supporting both corporate clients and private equity investors across Europe and Asia.
- Executed dozens of M&A, licensing, and strategic partnership transactions in biotech and medtech
- Advised Asian pharmaceutical companies on exclusive partnership and licensing deals with major European counterparts
- Supported European life science companies and private equity investors with target scouting and commercial due diligence
- Worked hands-on across deal structuring, negotiations, and cross-border execution in complex, multi-party transactions
